Go to:
Logótipo
Você está em: Start > Publications > View > Imiquimod-Loaded Nanosystem for Treatment Human Papillomavirus-Induced Lesions
Publication

Imiquimod-Loaded Nanosystem for Treatment Human Papillomavirus-Induced Lesions

Title
Imiquimod-Loaded Nanosystem for Treatment Human Papillomavirus-Induced Lesions
Type
Article in International Scientific Journal
Year
2024
Authors
Maocha, I
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rosado, B
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lopes-Nunes, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lopes, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rolo, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pires, B
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gallardo, E
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Palmeira-de-Oliveira, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Martinez-de-Oliveira, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
de Oliveira, RP
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rui Medeiros
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Cruz, C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: PharmaceuticsImported from Authenticus Search for Journal Publications
Vol. 25
Final page: 864
ISSN: 1999-4923
Publisher: MDPI
Other information
Authenticus ID: P-010-NYR
Abstract (EN): <jats:p>Human papillomavirus (HPV)-associated cervical cancer is the most common cancer among women worldwide. The treatment options are strongly related to increased infertility in women. Imiquimod (IQ) is an imidazoquinoline, which has proven antiviral effects against persistent HPV infection by activating immune cells via Toll-like receptors 7/8 when formulated in carriers, like nanogels, for topical use. An effective alternative to conventional therapies is the nanoparticle drug delivery system. We studied lipidic nanoparticles with IQ (Lipo IQ) and functionalized them with a DNA aptamer, AT11 (Lipo IQ AT11), to improve the selectivity for cervical cancer cells combined with the efficacy of essential oils. The formulations showed that the physicochemical properties are adequate for vaginal drug delivery and have antimicrobial activity at higher concentrations (with MIC50 starting from 0.625%). The final formulations exhibited cytotoxicity in cancer cells, enhanced by essential oils without affecting healthy cells, resulting in less than 10% cell viability in HeLa cells and over 60% in NHDF cells. Essential oils potentiate Lipo IQ¿s effectiveness, while AT11 increases the selectivity for cervical cancer cells. As suggested by the results of the permeation assay, the formulations were internalized by the cancer cells. Overall, the obtained results suggested that the synergistic effect of the essential oils and the nanosystem potentiate the cytotoxic effect of Lipo IQ and that Lipo IQ AT11 promotes selectivity towards cancer cells.</jats:p>
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Second-Generation Antimitotics in Cancer Clinical Trials (2021)
Another Publication in an International Scientific Journal
Novais, P; Silva, PMA; Maria Isabel Amorim; Bousbaa, H
Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies (2020)
Another Publication in an International Scientific Journal
Teixeira, MI; Maria Helena Amaral; Paulo Costa; Lopes, CM; Lamprou, DA
Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence (2020)
Another Publication in an International Scientific Journal
Menditto, E; Orlando, V; De Rosa, G; Minghetti, P; Musazzi, UM; Cahir, C; Kurczewska Michalak, M; Kardas, P; Costa, E; Sousa Lobo JM; Almeida, IF
Nanopharmaceutics: Part I-Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU (2020)
Another Publication in an International Scientific Journal
Souto, EB; Silva, GF; Dias Ferreira, J; Zielinska, A; Ventura, F; Durazzo, A; Lucarini, M; Novellino, E; Santini, A
Magnetic Bone Tissue Engineering: Reviewing the Effects of Magnetic Stimulation on Bone Regeneration and Angiogenesis (2023)
Another Publication in an International Scientific Journal
Ribeiro, TP; Flores, M; Madureira, S; Zanotto, F; Fernando Mendes Monteiro; Laranjeira, MS

See all (95)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Arquitectura da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2024-11-08 at 23:18:41 | Acceptable Use Policy | Data Protection Policy | Complaint Portal